12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus

12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus

Simone Perna,1 Manuela Mainardi,2 Paolo Astrone,2 Carlotta Gozzer,3 Anna Biava,1 Ruben Bacchio,3 Daniele Spadaccini,3 Sebastiano Bruno Solerte,2 Mariangela Rondanelli4 1Department of Biology, College of Science, University of Bahrain, Sakhir Campus, Kingdom of Bahrain; 2University of Pavia, Departme...

Full description

Saved in:
Bibliographic Details
Main Authors: Perna S, Mainardi M, Astrone P, Gozzer C, Biava A, Bacchio R, Spadaccini D, Solerte SB, Rondanelli M
Format: article
Language:EN
Published: Dove Medical Press 2018
Subjects:
SGLT-2 inhibitors
incretins
cognitive performance
cognitive impairment
metabolic outcome
Therapeutics. Pharmacology
RM1-950
Online Access:https://doaj.org/article/c9d8c56def4e472a811b5b030a362e07
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/c9d8c56def4e472a811b5b030a362e07

Similar Items